Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

192.05USD
8 Sep 2016
Change (% chg)

-- (--)
Prev Close
$192.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
677
52-wk High
$195.20
52-wk Low
$133.25

Summary

Name Age Since Current Position

Rolf Soiron

71 2012 Chairman of the Board of Directors

Richard Ridinger

58 2012 Chief Executive Officer and Member of the Executive Committee

Patrick Aebischer

62 2014 Vice-Chairman of the Board of Directors

Toralf Haag

50 2005 Chief Financial Officer, Member of the Executive Committee

Sven Abend

48 2016 Chief Operating Officer - Specialty Ingredients, Member of the Management Board, Chief Strategy Officer

Marc Funk

56 2015 Chief Operating Officer, Member of the Management Board

Werner Bauer

66 2013 Member of the Board of Directors

Thomas Ebeling

57 2013 Member of the Board of Directors

Jean-Daniel Gerber

70 2011 Member of the Board of Directors

Christoph Maeder

56 2016 Member of the Board of Directors

Barbara Richmond

56 2014 Member of the Board of Directors

Margot Scheltema

62 2012 Member of the Board of Directors

Juergen Steinemann

58 2014 Member of the Board of Directors

Antonio Trius

61 2013 Member of the Board of Directors

Biographies

Name Description

Rolf Soiron

Dr. Rolf Soiron is Chairman of the Board of Directors of Lonza Group Ltd since April 11, 2005. He is Member of the Nomination and Compensation Committee of the Company. From January 24, 2012 to April 30, 2012, he was also Interim Chief Executive Officer of the Company. He is Member of Innovation and Technology Committee. From 2003 to 2010, he served as Chairman of the Board of Directors of Nobel Biocare Holding Ltd. He has been Member of the Board of Directors of Holcim Ltd, since 1994, and its Chairman since 2003. He has been Member of the Board of Directors of Jungbunzlauer Group since 1993. He served as Managing Director of Jungbunzlauer Group from 2001 till 2003. He served as Chief Executive Officer of Jungbunzlauer Group from 1993 till 2001. He served as Chief Operating Officer and Head of Pharma at Sandoz Group, from 1992 till 1993, and as Group Vice-President Agribusiness USA from 1988 till 1992. He served as President and Chief Executive Officer of Protek Group from 1983 till 1987. He held various functions in Human Resources, Finance and Corporate at Sandoz Group from 1982 till 1983. He has been Chairman of the Foundation Council of Avenir Suisse since 2009. Furhermore, he has been Member of the International Committee of the Red Cross since 2009. He has been Member of the Board of economiesuisse since 2009. He has served as Chairman of the Basel University Council from 1995 till 2005. He is Accredited Business Accountant. He holds a Doctorate in Philosophy in History from Universitaet Basel, obtained in 1972, and a Professional Masters Degree (PMD) from Harvard Business School.

Richard Ridinger

Mr. Richard Ridinger is Chief Executive Officer and Member of the Executive Committee of Lonza Group Ltd since May 1, 2012. He holds a degree in chemical engineering from Universitaet Karlsruhe. His former activities include Member of the Management Board and Executive Vice-President Care Chemicals at Cognis GmbH from 2006 to 2010 and Transfer and integration of Cognis GmbH into BASF (2011), SBU Head of Cognis Care Chemicals and member of the Cognis Executive Committee (2002 - 2006), Vice-President of the global Care Chemicals Specialties business of Cognis GmbH (2000 - 2002), Director global Skin Care Ingredients Business at Henkel KGaA / Cognis GmbH (1999 - 2000), and various positions at Henkel KGaA (1986 - 1999).

Patrick Aebischer

Mr. Patrick Aebischer is Vice-Chairman of the Board of Directors of Lonza Group Ltd since 2014. He was Member of the Board of Directors from March 26, 2008 until 2014. He is Chairman of the Innovation and Technology Committee at the Company. He serves as Member of the Board of Directors of Nestle SA (since April 2015), Chairman of the Advisory Board of the Novartis Venture Fund (since 2014), Member of the Foundation Board of the Wyss Center for Bio and Neuro Engineering (since 2014), Member of the Foundation Board of the World Economic Forum (since 2013), Member of the Singapore Biomedical Sciences International Advisory Council (since 2013). Since 2000, He has been the President of the Swiss Federal Institute of Technology (EPFL) in Lausanne and Professor of Neurosciences at EPFL. In addition, he has been Fellow of the American Institute for Medical and Biological Engineering since 2000. He also acted as Fellow of the Swiss Academy of Medical Sciences since 1998. He is Founder of three biotechnology companies. He holds a Doctorate in Medicine from Universite de Geneve. He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medical Sciences and the Pfizer Foundation Prize for Clinical Neurosciences.

Toralf Haag

Mr. Toralf A. Haag has decided to step down as Chief Financial Officer and Member of the Executive Committee of Lonza Group Ltd effective October 1, 2016, where he served since August 2005. Currently he serves as Member of the Board of Fr. Sauter AG, Basel (since February 2014), scienceindustries (since 2012), Vereinigung Schweizer Finanzchefs (VSF) (since 2009). He served as Chief Financial Officer and Member of the Management Board at Norddeutsche Affinerie AG from 2002 to 2005. Prior to that, he acted as Chief Executive Officer (President) Stamping & Frame Division of The Budd Company Detroit from 2000 till 2001 and as Director Finance, M&A (Mergers and Acquisitions) and Corporate Development, at The Budd Company Detroit from 1997 to 1999. Between 1994 and 1996, he served as Assistant to the Chief Executive Officer of Thyssen Handelsunion AG. He graduated from Christian-Albrechts-Universitaet zu Kiel with a Doctorate in Philosophy degree and from Universitat Augsburg with a degree in Business Administration. Since 2012,

Sven Abend

Mr. Sven Abend is Chief Operating Officer - Specialty Ingredients, Member of the Management Board and Chief Strategy Officer of Lonza Group Ltd since January 1, 2016. Previously he served as Member of the Executive Committee of Lonza Group Ltd., since July 1, 2014 till January 1, 2016. He had primary responsibility for Corporate Strategy and Business Development, as well as Consumer Care and Industrial Solutions, and focused delivery of Lonza's growth strategy. He serves as Chief Executive Officer of Kolb Ltd in Hedingen, Switzerland (2012 – 2014), Business Manager for Kolb’s divisions focusing on specialty surfactants and custom manufacturing (2010 – 2012), Several senior positions in Global Product Management and ultimately as Director of Corporate Key Account Management at Cognis GmbH in Germany (2003 – 2010), Project Scientist for the R&D Home & Personal Care business at Unilever in the UK (2000 – 2003). He received his Ph.D. in Chemistry from the Christian-Albrechts-Universität in Kiel, Germany, and worked on his post-doctorate at the State University of New York in Stony Brook, New York (USA).

Marc Funk

Mr. Marc Funk is Chief Operating Officer Pharma&Biotech Segment and Member of the Management Board of Lonza Group Ltd since March 2015. He was Chief Legal Officer at the Company until March 2015, the positions he has held since April 2012. He has been with the Company since March 2011, when he took the position of Group General Counsel and Board Secretary. Prior to Lonza, He was General Counsel of GeneProt from 2000 to 2004, and Associate General Counsel of Merck Serono from 2004 to 2008. He holds a Master of Law from Universite de Geneve and a Master of Law and Diplomacy from the Fletcher School (Tufts University MA).

Werner Bauer

Prof. Dr.-Ing. Werner J. Bauer is Member of the Board of Directors of Lonza Group Ltd since April 2013. He is also Member of Innovation and Technology Committee. He is Member of the Board of Directors of Givaudan SA (since 2014), Member of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012) and Chairman of the Board of Trustees of the Bertelsmann Foundation (since 2011), Member of the Supervisory Board of GEA-Group AG (since 2011), Member of the Board of Directors of Galderma Pharma (since 2011), Member of the Supervisory Board of Nestlé Deutschland AG (since 2007). During his professional career, he was Head of Innovation, Technology, Research and Development of Nestle S.A. (2007–August 2013), Executive Vice-President of Nestle S.A. (2002–2007). He also held various managerial positions of increasing responsibility at Nestle (1990–2002), Director of the Fraunhofer Institute for Food Technology & Packaging (1985–1990), Professor of Chemical Engineering at the Technical University of Hamburg (1980–1985). He holds a diploma and PhD in Chemical Engineering from the University Erlangen-Nuernberg. He has received several scientific honors, among others, such as the BioAlps Award 2011 and the Honorary Senator from the Technical University of Munich.

Thomas Ebeling

Mr. Thomas Ebeling is Member of the Board of Directors of Lonza Group Ltd since April 2013. He is Member of the Nomination and Compensation Committee. Currently, he is also Member of the Advisory Board / MPM Oncology Investments LLC (since January 2016), Member of the Advisory Board / Auris Luxembourg III S.a r.l. (since 2015), Founder of Better Life Healthcare (since 2015), Member of the Supervisory Board of Bayer AG (since 2012), Advisor to TPG Biotech Fund (since 2011), Chief Executive Offier of ProSiebenSat1. Media AG (since 2009). Prior to this, he was Chief Executive Officer of the Novartis Consumer Health Division (2007–2008), Chief Executive Officer of the global Novartis pharmaceuticals business (2000–2007), Head of Novartis Nutrition Division (1998–2000), General Manager of Novartis Nutrition for Germany and Austria (1997–1998). He holds a Master’s degree in Psychology from the Universitaet Hamburg (University of Hamburg).

Jean-Daniel Gerber

Mr. Jean-Daniel Gerber is Member of the Board of Directors of Lonza Group Ltd since April 2011. He is Chairman of the Nomination and Compensation Committee and he was Member of the Audit and Compliance Committee at the Company. Currently, he serves as Chairman of the Association “Swiss Sustainable Finance” (since 2015), Vice-President of the Association “Platform Switzerland Europe” (since 2015), Member of the AO Alliance Foundation (since 2015), Chairman of the Board of the Swiss Investment Fund for Emerging Markets (SIFEM) (since 2011), Chairman of the Swiss Society for Public Good (since 2011). Prior to that, he served as Director of the State Secretariat for Economic Affairs (SECO) with the title of State Secretary from 2004 to 2011. He was also Director of the Federal Office for Migration (then Federal Office for Refugees) in the Federal Department of Justice and Police between 1997 and 2004. From 1993 to 1997 he acted as Executive Director at the World Bank and Dean of the Executive Directors of the World Bank Group from 1996 to 1997. Between 1991 and 1992, Mr. Gerber acted as Chief of Section for Developing Countries in the former Federal Office for Foreign Economic Affairs. He holds a lic. rer. pol in Economics from Universitaet Bern. He was also awarded an honorary doctorate by the Faculty of Economics and Social Sciences of Universitaet Bern.

Christoph Maeder

Mr. Christoph Maeder is Member of the Board of Directors of Lonza Group Ltd since April 22, 2016. He is Vice Chairman of economiesuisse, the main umbrella organization representing the Swiss economy. He holds a Master’s degree in Law from the University of Basel and is admitted to the Swiss Bar.

Barbara Richmond

Ms. Barbara Richmond is Member of the Board of Directors of Lonza Group Ltd since April 2014. She is Member of the Audit and Compliance Committee at the Company. She also serves as Group Chief Financial Officer at Redrow plc since 2010. From 2006 - 2009 she served at Inchcape plc as Group Chief Financial Officer. She also served as Non-Executive Director and Audit Committee Chair of Scarborough Building Society until its merger with The Skipton Building Society (2005 – 2009), Non-Executive Director, Senior Independent Director and Audit Committee Chair of Carclo Group PLC (2000 – 2006), Group Chief Financial Officer of Croda International plc (1997 – 2006) with dual role as Group Chief Financial Officer and President of Active Ingredients and Industrial Chemicals from 2002 to 2006, Group Chief Financial Officer of Whessoe plc in1993 (1992 – 1997), Various financial roles in Alstom Group SA (1987 – 1992), Auditor and management consultant for Arthur Andersen (1981 – 1984). She Holds a First Class degree in Management Science from the University of Manchester Institute of Science and Technology in England. She is a Fellow of the Institute of Chartered Accountants in England and Wales.

Margot Scheltema

Ms. Margot Scheltema is Member of the Board of Directors of Lonza Group Ltd since April 1, 2012. She is Chairwoman of the Audit and Compliance Committee of the Company. She also serves as Member of the Supervisory Board of the Dutch Central Bank (since 2015), Member of the Central Plan Committee Dutch Planning Bureau (since 2014), Chair of the Monitoring Committee of the Dutch Pension Fund Code (since 2014), Counsel to the Enterprise Chamber of the Amsterdam Court of Appeal (since 2013), Member of the Supervisory Board of Warmtebedrijf Rotterdam, TNT Express, Schiphol NV (since 2010), Vice-Chair of Triodos Bank’s Supervisory Board, and Member of the Supervisory Board of ASR NV, among others. She holds a doctorate in international law from Universiteit van Amsterdam and a master of international affairs (MIA) from Columbia University in New York.

Juergen Steinemann

Mr. Juergen Steinemann is Member of the Board of Directors at Lonza Group Ltd since April 2014. He is Member of the Nomination and Compensation Committee at the Company. Currently, he serves as Member of the Board of Directors of Barry Callebaut AG (since 2015), Member of the Supervisory Board of Metro Group AG (since 2015), Big Dutchman AG (since 2015), Ewald Dorken AG (since 2002), Member of the Board of the Swiss-American Chamber of Commerce (since 2011). Previously, he served at Chief Executive Officer of Barry Callebaut Ltd (since 2009 - 2015), Member of the Supervisory Board of Ewald Doerken AG (since 2002), Member of the Board of the Swiss-American Chamber of Commerce (since 2011). He also served at Member of the Executive Board and Chief Operating Officer of Nutreco (2001 – 2009), Chief Executive Officer of Loders Croklaan (1999 – 2001) and Various senior positions in business-to-business marketing and sales with the former Eridania Beghin-Say Group, ultimately in the “Corporate Plan et Strategie” unit at the head office in Paris (1990 – 1998). He holds a degree in Economics and Business Management from the European Business School in Wiesbaden, London and Paris.

Antonio Trius

Dr. Antonio Trius is Member of the Board of Directors of Lonza Group Ltd since April 2013. He is also Member of the Audit and Compliance Committee. He is Member of the Board of Directors of MaxamCorp Holding S.L. (since 2014), Azelis SA (since February 2014), Member of the Supervisory Board of Altana AG (since 2012), Member of the Board of Directors of Nubiola SL (since 2011). During his professional career, he was also Chief Executive Officer of Cognis GmbH (2001–2010), Executive Vice President Care Chemicals North America (1999–2001) and Vice President Care Chemicals at Henkel KGaA (1997–1999). He holds a Bachelor in Organic Chemistry from the University of Barcelona, a PhD in Chemistry from the Autonomous University of Barcelona and a PDD in Business Administration from the IESE Barcelona.

Basic Compensation